Clinical Trial Update: Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation) [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study updating safety and efficacy information for Jivi in patients with severe Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Jivi

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2023-06-28